JGC
KURA icon

J. Goldman & Co’s Kura Oncology KURA Stock Holding History

J. Goldman & Co’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31,654
Closed -$619K – 555
2024
Q3 		$619K Sell
31,654
-1,067
-3% -$21.6K 0.02% 333
2024
Q2 		$674K Buy
+32,721
New +$673K 0.02% 341
2020
Q4 		– Sell
-25,425
Closed -$779K – 435
2020
Q3 		$779K Sell
25,425
-26,910
-51% -$594K 0.05% 230
2020
Q2 		$853K Buy
+52,335
New +$755K 0.05% 204

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

J. Goldman & Co's KURA Position: Q4 2024 in Review

J. Goldman & Co sold out of Kura Oncology (KURA) in Q4 2024, closing a stake of 31,654 shares — an estimated $619K sold.

J. Goldman & Co first reported a position in KURA in Q2 2020 and held it in 4 quarters. The position peaked at $853K in Q2 2020. 185 funds tracked by Wall St. Rank hold KURA as of Q4 2024.

  • J. Goldman & Co reported no remaining Kura Oncology position as of Q4 2024 after selling out during the quarter.
  • J. Goldman & Co sold 31,654 Kura Oncology shares in Q4 2024, an estimated $619K.
  • J. Goldman & Co first reported a position in Kura Oncology in Q2 2020 and held it in 4 quarters.
  • J. Goldman & Co's Kura Oncology position peaked at $853K in Q2 2020.
  • 185 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2024.

Based on J. Goldman & Co's 13F filing for Q4 2024, filed 14 Feb 2025.